Vascular endothelial growth factor expression in early stage ovarian carcinoma
โ Scribed by Pamela J. Paley; Katherine A. Staskus; Kristin Gebhard; Dhanabal Mohanraj; Leo B. Twiggs; Linda F. Carson; Sundaram Ramakrishnan
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 436 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
VEGF expression. Antisense and corresponding sense (control) RNA probes were transcribed from the pCRII construct (Invitrogen, San Diego, CA), which con-
๐ SIMILAR VOLUMES
## BACKGROUND. Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumor angiogenesis, which is essential for the growth, invasion, and metastasis of solid tumors. This study examines the clinical significance of VEGF subtypes in ovarian carcinoma. ## METHODS.
We investigated the expression of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) in stab and freeze brain injury models in rats. Immunohistochemical staining with anti-VEGF antibodies demonstrated an increase in VEGF-positive cells in and around both lesions. Morphologi
Recently many studies have demonstrated that the degree of tumor angiogenesis is related to the aggressiveness of the tumor and clinical outcome. Vascular endothelial growth factor (VEGF) is a well characterized inducer of angiogenesis. In this study, the authors investigated the prognostic signifi
histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica